75 related articles for article (PubMed ID: 7415155)
1. [Treatment of diabetics with metformin].
Tikholov K; Kalpazanova N; Peshev P; Kostov M; Kusinikov V
Vutr Boles; 1980; 19(4):21-4. PubMed ID: 7415155
[TBL] [Abstract][Full Text] [Related]
2. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary findings on 2 groups of diabetics with regard to platelet aggregation in relation to retinopathy and ultimate relation to antidiabetic therapy].
Cavaliere R; Giangrandi E; Innocenti M; Parisi R
Minerva Med; 1978 Jun; 69(28):1923-8. PubMed ID: 662185
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
5. [Leo-insulins in the treatment of diabetes. Experiences from an internal medicine practice].
Roth U
Fortschr Med; 1980 Jul; 98(25):995-8. PubMed ID: 7005038
[TBL] [Abstract][Full Text] [Related]
6. [Long-term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide-metformin].
Schulte J; García Viveros M; Rull J; Lozano-Castañeda O
Prensa Med Mex; 1973; 38(7):281-2. PubMed ID: 4789184
[No Abstract] [Full Text] [Related]
7. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
D'Argenzio R; Cavallo P; Merante D; Morelli A
Minerva Endocrinol; 1996 Sep; 21(3):101-10. PubMed ID: 9072666
[TBL] [Abstract][Full Text] [Related]
9. [Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide-metformin (author's transl)].
Díes H; Lozano Castañeda O; García Viveros M; Schulte J; Figueroa J; Rull JA
Rev Invest Clin; 1978; 30(2):131-4. PubMed ID: 353940
[No Abstract] [Full Text] [Related]
10. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Herman GA; Bergman A; Yi B; Kipnes M;
Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
[TBL] [Abstract][Full Text] [Related]
11. [The effect of antiaggregants on the course of diabetic microangiopathy].
Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
[TBL] [Abstract][Full Text] [Related]
12. [4 years of clinical experience with metformin in 47 diabetic patients].
Joncas F
Union Med Can; 1972 Jan; 101(1):65-70. PubMed ID: 5013455
[No Abstract] [Full Text] [Related]
13. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
Chazova I; Almazov VA; Shlyakhto E
Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
[TBL] [Abstract][Full Text] [Related]
14. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
Henricsson M; Nilsson A; Janzon L; Groop L
Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes.
Fanghänel G; Silva U; Sanchez-Reyes L; Sisson D; Sotres D; Torres EM
Rev Invest Clin; 1998; 50(5):389-94. PubMed ID: 9949668
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
Bhansali A; Masoodi SR
J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
[TBL] [Abstract][Full Text] [Related]
17. [Short-term and long-term effect of metformin in type 1 diabetics].
Lacigová S; Rusavý Z; Kyselová P; Jankovec Z; Kárová R; Cechurová D
Vnitr Lek; 2001 Feb; 47(2):81-6. PubMed ID: 15635851
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diagnosed type 2 diabetes mellitus in the French general population: the INSTANT study.
Bringer J; Fontaine P; Detournay B; Nachit-Ouinekh F; Brami G; Eschwege E
Diabetes Metab; 2009 Feb; 35(1):25-31. PubMed ID: 19046913
[TBL] [Abstract][Full Text] [Related]
20. [Value of delayed-action metformin in the treatment of diabetes].
Pousset G; Robert M; Guinet P
Lyon Med; 1971 Sep; 226(14):219-21. PubMed ID: 5117728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
